China SFDA Vows Quick Action To Prevent Gel-Capsule Scandal Repeat
This article was originally published in PharmAsia News
Executive Summary
China’s State FDA spread the word to local authorities to respond quickly and harshly to any reports of unsafe gel capsules found in their areas as part of a long-term monitoring system to prevent a scandal repeat.